close
close

Mondor Festival

News with a Local Lens

GeneDx Holdings: Phenomenal Gains, More Mid-Term Upside Potential (NASDAQ: WGS)
minsta

GeneDx Holdings: Phenomenal Gains, More Mid-Term Upside Potential (NASDAQ: WGS)

This article was written by

Profile photo of Edmund Ingham

Edmund Ingham is a biotechnology consultant. He has covered the biotechnology, healthcare and pharmaceutical industry for over 5 years and has written detailed reports on over 1,000 companies. He heads the investment group Haggerston BioHealth.

The group is aimed at both new and experienced biotechnology investors. It provides catalysts for researching and buying and selling notes. It also provides product sales and forecasts for all major pharmaceutical companies, forecasts, integrated financial statements, discounted cash flow analysis and market-by-market analysis. Learn more.

Analyst Disclosure: I/we do not have any positions in stocks, options or similar derivatives in any of the companies mentioned, and we do not intend to initiate such positions within the next 72 hours. I wrote this article myself and it expresses my own opinions. I receive no compensation for this (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Request Alpha Disclosure: Past performance does not guarantee future results. No recommendation or advice is given as to whether any investment is suitable for any particular investor. The views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities broker-dealer, investment advisor or investment bank in the United States. Our analysts are third-party authors who include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.